NCT04710849 is a clinical trial of Serum metabolic markers in COPD, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04710849?

NCT04710849 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04710849?

Interventions in NCT04710849: Serum metabolic markers.

What condition does NCT04710849 study?

NCT04710849 studies COPD, COPD Exacerbation Acute.

Is NCT04710849 still recruiting?

NCT04710849 is currently status unknown. Last updated 15 January 2021.

Last reviewed 2021-01-15 · How we verify

NCT04710849

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in AECOPD

Status unknown Last updated 15 January 2021

What this trial tests

trial testing Serum metabolic markers in COPD in 100 participants. Status unknown.

Timeline

1 February 2021

Primary endpoint
1 February 2024

1 June 2024

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 February 2021
Primary completion	1 February 2024
Estimated completion	1 June 2024
Sites	1 location across China

Drugs / interventions tested

Serum metabolic markers

Conditions studied

COPD — all drugs for COPD →
COPD Exacerbation Acute — all drugs for COPD Exacerbation Acute →

Sponsor

Peking University Third Hospital

Who can join

18 and older, any sex, with COPD or COPD Exacerbation Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) significantly increases the mortality of the patients with COPD. Guidelines have recommended systemic glucocorticoid as regular treatment. Recently, evidences have shown that systemic glucocorticoid cannot not be benefit to all of the patients with AECOPD. Thus the problem that how the clinicians can screen the patients who can benefit from systemic glucocorticoid needs to be solved urgently.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Rationale and design of REGULATE: an observational study protocol for relationship between plasma metabolome and the efficacy of systemic glucocorticoid in acute exacerbation of chronic obstructive pulmonary disease.
Li QY, An ZY, Pan ZH, Qi RY. · · 2021 · cited 1× · PMID 34320980 · DOI 10.1186/s12890-021-01614-3

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04710849 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 15 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing